Open AccessHelical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases
Author(s) -
Yoshiaki Yamada,
Yuta Shibamoto,
Kazushi Kishi,
Nozomi Kita,
Takuhito Kondo,
Taro Murai,
Chikao Sugie
Publication year - 2022
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.5603/rpor.a2022.0016
Subject(s) - medicine , tomotherapy , chemotherapy , asymptomatic , radiation therapy , refractory (planetary science) , surgery , gastroenterology , physics , astrobiology
Despite chemotherapy innovations, prognosis of patients with chemotherapy-refractory or -unfit multiple metastases (CRMM/CUMM) remains poor. In this prospective study, the efficacy and toxicity of helical tomotherapy for CRMM/CUMM were evaluated.